Delft, Netherlands

Eric Bastiaan Smaal


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Eric Bastiaan Smaal: Innovator in Steroid Oxidation**

Introduction

Eric Bastiaan Smaal is a distinguished inventor based in Delft, the Netherlands. He has made significant contributions to the field of biochemistry and pharmaceuticals, holding a total of three patents. His innovative work primarily focuses on the processes involved in the oxidation of steroids, showcasing his expertise and creativity in the scientific arena.

Latest Patents

Among Eric’s notable inventions is a process for the oxidation of steroids, which integrates genetically engineered cells to enhance efficacy. This advancement holds the potential for major implications in both medicinal and industrial applications, reflecting his commitment to pushing the boundaries of biotechnological innovations.

Career Highlights

Eric has had a fruitful career, contributing to reputable companies such as Hoechst Marion Roussel and Aventis Pharma S.A. His roles at these organizations have provided him with a platform to develop and refine his innovative ideas, aiding in the advancement of pharmaceutical research and development.

Collaborations

Throughout his career, Eric has collaborated with several talented professionals, including Herman Slijkhuis and Gerardus Cornelis Maria Selten. These partnerships have been instrumental in fostering a collaborative environment that drives innovation and leads to groundbreaking discoveries in the field.

Conclusion

As an accomplished inventor, Eric Bastiaan Smaal continues to make strides in the world of science and innovation. His work, particularly in the oxidation of steroids and the use of genetically engineered cells, illustrates the importance of creativity and research in driving forward the frontiers of technology and health. With a firm foundation in both collaboration and industry experience, Eric's contributions are sure to impact the pharmaceutical landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…